Cassava Sciences, Inc.
SAVA
$2.05
-$0.07-3.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 63.75% | 65.67% | -152.94% | -147.43% | -137.76% |
| Gross Profit | -63.75% | -65.67% | 152.94% | 147.43% | 137.76% |
| SG&A Expenses | 258.68% | 301.66% | 349.91% | 327.43% | 39.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.31% | 28.14% | 33.28% | 38.26% | 15.29% |
| Operating Income | -31.31% | -28.14% | -33.28% | -38.26% | -15.29% |
| Income Before Tax | -51.95% | 74.96% | 81.49% | 82.93% | 42.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.95% | 74.96% | 81.49% | 82.93% | 42.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.95% | 74.96% | 81.49% | 82.93% | 42.28% |
| EBIT | -31.31% | -28.14% | -33.28% | -38.26% | -15.29% |
| EBITDA | -32.16% | -28.93% | -34.11% | -38.96% | -15.45% |
| EPS Basic | -30.52% | 81.00% | 84.18% | 82.13% | 43.36% |
| Normalized Basic EPS | -3.30% | 85.86% | 80.24% | 79.05% | 40.06% |
| EPS Diluted | 30.29% | 37.55% | 39.88% | 35.71% | -6.28% |
| Normalized Diluted EPS | -2.23% | 85.31% | 79.68% | 78.47% | 39.43% |
| Average Basic Shares Outstanding | 12.76% | 10.47% | 7.85% | 5.50% | 3.94% |
| Average Diluted Shares Outstanding | 12.03% | 11.12% | 8.51% | 6.17% | 4.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |